LISANTI CAPITAL GROWTH, LLC Apellis Pharmaceuticals, Inc. Transaction History

LISANTI CAPITAL GROWTH, LLC portfolio value:

$13.47M
portfolio value

LISANTI CAPITAL GROWTH, LLC quarter portfolio value change:

+51.04%
quarter

Apellis Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +52.34% 67.78K shares 7.61M $68.3 197.29K
Q2 2022 share Increase +158.81% 79.46K shares 3.31M $45.22 129.50K
Q1 2022 share Decrease -51.62% -53.38K shares -2.34M $50.81 50.04K
Q4 2021 share Increase 0.00% 103.42K shares 4.89M $47.95 103.42K
Q3 2021 share Decrease -100.00% -119.44K shares -7.54M $32.96 0
Q2 2021 share Increase 0.00% 119.44K shares 7.54M $63.2 119.44K
Q1 2021 share Decrease -100.00% -134.94K shares -7.71M $42.91 0
Q4 2020 share Increase 0.00% 134.94K shares 7.71M $57.2 134.94K
Q2 2020 share Decrease -100.00% -28.35K shares -759K $32.66 0
Q1 2020 share Increase 0.00% 28.35K shares 759K $26.79 28.35K